logo-loader
viewSingh Biotechnology

Full interview: Singh Biotechnology's low-cost virtual company model advances cancer therapies rapidly

Singh Biotechnology CEO Dr Sunanda Singh tells Proactive the Florida-based 'virtual' biotech, who outsources all of its R&D to contract resource companies in the US, is in the late pre-clinical stage with its therapies to treat pancreatic and bone cancer. Singh says staying virtual allows the privately-held company to keep costs down.

Singh is looking to raise more capital to push its therapies to Phase 1 studies.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arizona Silver Exploration buys out claims saving hundreds...

Arizona Silver Exploration (CVE: AZS) President and CEO Mike Stark sat down with Steve Darling from Proactive Vancouver to bring news the Arizona Silver has bought out the remaining claims on their Philadelphia project. That move wills ave the company half a million dollars going...

17 minutes ago

2 min read